Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Int J Mol Sci ; 23(18)2022 Sep 07.
Article in English | MEDLINE | ID: covidwho-2010119

ABSTRACT

COVID-19 is a severe respiratory disease threatening pregnant women, which increases the possibility of adverse pregnancy outcomes. Several recent studies have demonstrated the ability of SARS-CoV-2 to infect the mother enterocytes, disturbing the gut microbiota diversity. The aim of this study was to characterize the entero-mammary microbiota of women in the presence of the virus during delivery. Fifty mother-neonate pairs were included in a transversal descriptive work. The presence of SARS-CoV-2 RNA was detected in nasopharyngeal, mother rectal swabs (MRS) and neonate rectal swabs (NRS) collected from the pairs, and human colostrum (HC) samples collected from mothers. The microbiota diversity was characterized by high-throughput DNA sequencing of V3-16S rRNA gene libraries prepared from HC, MRS, and NRS. Data were analyzed with QIIME2 and R. Our results indicate that several bacterial taxa are highly abundant in MRS positive for SARS-CoV-2 RNA. These bacteria mostly belong to the Firmicutes phylum; for instance, the families Bifidobacteriaceae, Oscillospiraceae, and Microbacteriaceae have been previously associated with anti-inflammatory effects, which could explain the capability of women to overcome the infection. All samples, both positive and negative for SARS-CoV-2, featured a high abundance of the Firmicutes phylum. Further data analysis showed that nearly 20% of the bacterial diversity found in HC was also identified in MRS. Spearman correlation analysis highlighted that some genera of the Proteobacteria and Actinobacteria phyla were negatively correlated with MRS and NRS (p < 0.005). This study provides new insights into the gut microbiota of pregnant women and their potential association with a better outcome during SARS-CoV-2 infection.


Subject(s)
COVID-19 , Gastrointestinal Microbiome , Anti-Inflammatory Agents , Bacteria/genetics , Female , Firmicutes/genetics , Gastrointestinal Microbiome/genetics , Humans , Infant, Newborn , Infectious Disease Transmission, Vertical , Pregnancy , RNA, Ribosomal, 16S/genetics , RNA, Viral , SARS-CoV-2
2.
Card Electrophysiol Clin ; 14(1): 63-70, 2022 03.
Article in English | MEDLINE | ID: covidwho-1487628

ABSTRACT

Numerous systemic manifestations, including cardiac involvement in the form of myocardial infarction, myocarditis, and electrocardiographic changes, have been associated with COVID-19..In this review, the authors describe the electrocardiographic features that have been reported to date in patients affected by this disease and their possible underlying mechanisms.


Subject(s)
COVID-19 , Myocardial Infarction , Myocarditis , Electrocardiography , Humans , SARS-CoV-2
3.
Int J Infect Dis ; 100: 21-24, 2020 Nov.
Article in English | MEDLINE | ID: covidwho-959809

ABSTRACT

Although COVID-19 in pregnant women and their neonates has been demonstrated, there is not enough evidence about how this vertical transmission occurs. This report describes a SARS-CoV-2 infection in a 21-year-old mother-daughter duo at the time of birth, focusing on the viral RNA detection in the stool of both and the human breast milk.


Subject(s)
Betacoronavirus/isolation & purification , Coronavirus Infections/transmission , Feces/virology , Infectious Disease Transmission, Vertical , Milk, Human/virology , Pneumonia, Viral/transmission , Pregnancy Complications, Infectious/virology , COVID-19 , Coronavirus Infections/virology , Female , Humans , Infant, Newborn , Mexico , Pandemics , Pneumonia, Viral/virology , Pregnancy , SARS-CoV-2 , Young Adult
4.
J Interv Card Electrophysiol ; 59(3): 485-493, 2020 Dec.
Article in English | MEDLINE | ID: covidwho-893308

ABSTRACT

PURPOSE: Cardiac involvement with COVID-19 infection has become evident by elevated troponin, cardiac arrhythmias, ST segment elevation, myocarditis, fulminant heart failure, and sudden cardiac death. We aimed to describe the association of COVID-19 and T-wave inversion (TWI) in a large case series. METHODS: We conducted an observational, retrospective study of confirmed COVID-19 cases with at least one electrocardiogram (ECG) in a large hospital in New York City (March 23, 2020-April 23, 2020). Patients with new TWI or pseudonormalization were further analyzed. Mortality and the need for invasive mechanical ventilation were the main outcomes. RESULTS: A total of 3225 patients were screened; 195 (6%) were selected for further analysis: 181 with TWI and 14 with T-wave pseudonormalization. Mean age was 66 ± 7 years; 51% were male. TWI were more commonly noted in the lateral (71%), followed by anterior (64%), inferior (57%), and septal (26%) leads. A total of 44 patients (23%) had elevated troponin. A total of 50 patients died (26%). Mortality rates of 35%, and 52% were observed in patients with diffuse TWI, and elevated troponin, respectively. Mortality rate of 80% was observed in patients with both elevated troponin and diffuse TWI. Additionally, 30% of the entire cohort and 58% of patients with elevated troponin required invasive mechanical ventilation. CONCLUSION: Our study demonstrates that new TWI is a relatively common finding in COVID-19 patients. Importantly, our findings suggest that new TWI or T-wave pseudonormalization, particularly with elevated troponin, was associated with higher rates of mechanical ventilation and in-hospital mortality.


Subject(s)
COVID-19/physiopathology , Ventricular Function , Aged , COVID-19/epidemiology , COVID-19/mortality , Electrocardiography , Female , Humans , Male , New York City/epidemiology , Respiration, Artificial , Retrospective Studies , SARS-CoV-2 , Troponin/blood
SELECTION OF CITATIONS
SEARCH DETAIL